Anaergia Inc. Announces $60 Million Bought Deal Offering of Subordinate Voting Shares
Retrieved on:
Wednesday, March 30, 2022
Offering, Company, Exercise, Corporate communication, Marketing, Issue, Natural gas, Sale, WIRE, Legislation, Toronto Stock Exchange, Ownership, SEDAR, Digestion, Plant, SEC Rule 144A, Greenhouse, TSX, Agriculture, Prospectus, Municipal solid waste, Tønder, GLOBE, RNG, Chair, NOT, TD, News, BOO, Efficiency, IPO, NEWS, FOR, Water, Security (finance), Renewable energy, Share (finance), BURLINGTON
BURLINGTON, Ontario, March 30, 2022 (GLOBE NEWSWIRE) -- Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) today announced that it has entered into an agreement to sell, on a bought deal basis, 4,800,000 subordinate voting shares (the “Shares”) at a price of $12.50 per Share (the “Issue Price”) to a syndicate of underwriters led by TD Securities Inc. (the “Underwriters”) for gross proceeds of approximately $60 million (the “Offering”).
Key Points:
- If the Over-Allotment Option is exercised in full, the gross proceeds to the Company will be approximately $69 million.
- As part of the Offering and pursuant to his pre-emptive rights, Dr. Andrew Benedek, the Chair and Chief Executive Officer of the Company, has agreed to purchase approximately $5 million of the Shares, being 400,000 Shares, at the Issue Price as part of the Offering.
- Dr. Benedek currently holds an approximate 54.8% economic interest and 82.9% voting interest in the Company through ownership of multiple voting shares of the Company.
- The Shares have not been, and will not be, registered under the U.S. Securities Act, or any state securities laws.